What Are Clue Cells on a Wet Prep Test?

Clue cells are vaginal epithelial cells so heavily coated with bacteria that their normally sharp edges look fuzzy or stippled under the microscope. They are the hallmark finding of bacterial vaginosis (BV), the most common vaginal infection in reproductive-age women. When a clinician performs a wet prep, or wet mount, they place a drop of vaginal fluid on a glass slide with a drop of saline and examine it at low and high magnification. If the borders of the flat squamous cells are obscured by a dense layer of small rods and coccobacilli, those cells are reported as clue cells, and BV becomes the leading diagnosis.

What You Are Actually Seeing Under the Microscope

A normal vaginal epithelial cell viewed under a microscope has a clean, well-defined outline. You can see the edge of the cell crisply, and the surface looks relatively smooth. A clue cell, by contrast, has so many bacteria stuck to it that the margin becomes granular and indistinct, sometimes described as looking like the cell was rolled in ground pepper. The bacteria responsible are overwhelmingly from the species Gardnerella vaginalis, though other anaerobes can pile on as well.

The attachment is not random. In vitro work has shown that Gardnerella vaginalis adheres best to vaginal epithelial cells at a pH between 5 and 6, which is higher than the healthy vaginal pH of roughly 3.8 to 4.5.¹ In a healthy vaginal environment, Lactobacillus species dominate and produce lactic acid and other antimicrobial compounds that keep the pH low and competing bacteria in check.² When that Lactobacillus population declines and the pH rises, Gardnerella and other anaerobes proliferate, and conditions become ideal for the bacteria to latch onto the epithelial cells and form clue cells.

Why Clue Cells Matter So Much for Diagnosis

Clinicians have several bedside clues they use to diagnose BV, grouped together as the Amsel criteria. These include a thin, grayish-white vaginal discharge, a vaginal pH above 4.5, a fishy odor when the discharge is mixed with potassium hydroxide (the “whiff test”), and the presence of clue cells on the wet mount. A diagnosis of BV is typically made when at least three of these four criteria are met.

Among the four criteria, clue cells consistently stand out as the single most reliable. One study found that clue cells on a wet mount had a sensitivity of about 98% and a specificity of about 94%, meaning they correctly identified almost all women who had BV and rarely flagged women who did not.³ Another study reported clue cell specificity at 100%, with no false positives at all.⁴ A third study found clue cells had the highest sensitivity (95%) and specificity (90%) among all the individual Amsel criteria.⁵ By comparison, vaginal pH alone has high sensitivity but poor specificity, because many things besides BV can raise vaginal pH, and the whiff test has low sensitivity, catching only a fraction of true cases.

This is why clinicians pay so much attention to the clue cell line on your wet prep report. A positive finding is strong evidence of BV on its own. When clue cells are combined with a positive whiff test, the specificity approaches near-perfect levels.³

True Clue Cells Versus Pseudo Clue Cells

Not every cell that looks like a clue cell under the microscope actually is one, and this distinction has only recently gotten serious research attention. A 2022 study using advanced microscopy found that true clue cells, where Gardnerella species directly and cohesively adhere to the epithelial cell surface, appeared in only about 56% of the BV samples examined. In the rest, the epithelial cells were simply mechanically trapped inside masses of bacteria floating in the vaginal fluid, creating what the researchers called “pseudo clue cells.” The bacteria were not actually attached to the cell surface; they were just surrounding it.⁶

The practical difference matters. Both true and pseudo clue cells can look similar on a standard wet mount, and both indicate that BV-associated bacteria have overgrown the vaginal environment. But the study also found considerable variation across clinical sites: the proportion of women with true clue cells ranged from 19% to 80% depending on the gynecologic practice.⁶ This suggests that the biological mechanism behind clue cell formation is more varied than textbooks typically present, and that inter-examiner variability in reading wet mounts is a real issue. Identifying a clue cell still depends on the experience and judgment of whoever is looking through the microscope.

What a BV Diagnosis Means for You

If your wet prep comes back positive for clue cells and your provider diagnoses BV, the condition itself is not dangerous in most cases but is annoying and, if left untreated, can raise the risk of certain complications. BV is the result of an imbalance in vaginal bacteria rather than a single invading pathogen, which is why it is technically called a dysbiosis rather than a traditional infection. The thin, off-white discharge and fishy smell that often accompany it are caused by the metabolic byproducts of the anaerobic bacteria that have overgrown.

About half of women with BV have no symptoms at all, which is part of why it turns up unexpectedly on routine wet preps or during prenatal screening. The condition was first described in 1955 when researchers linked a bacterium now known as Gardnerella vaginalis to a syndrome of elevated vaginal pH, thin discharge, fishy odor, and bacteria-covered epithelial cells.⁷ Decades later, we understand that Gardnerella is the most common microorganism identified in BV but that the condition involves a whole community of anaerobes working in concert.²

Treatment and the Recurrence Problem

Standard treatment for BV involves metronidazole or clindamycin, taken orally or applied vaginally. Metronidazole vaginal gel is one of the most commonly prescribed options. In a large randomized trial, women treated with metronidazole gel had significantly higher clinical cure rates at both one week and three weeks compared with those using a placebo gel.⁸ The antibiotics are effective at knocking back the overgrown anaerobes and allowing Lactobacillus to recolonize.

The frustrating part is that BV comes back. Even when 30-day cure rates approach 80% after a week-long course of oral metronidazole, recurrence within 12 months is common.⁹ A major reason is that Gardnerella and its partners form a polymicrobial biofilm on the vaginal mucosa, a sticky, organized community of bacteria that is much harder for antibiotics to penetrate than free-floating organisms.⁹ The biofilm can persist even after symptoms resolve and the clue cells disappear from a follow-up wet prep, setting the stage for the whole cycle to restart.

If you have had BV three or more times in a year, your provider may recommend a longer suppressive course of metronidazole gel. Researchers have also explored whether treating sexual partners reduces recurrence, since there is evidence linking semen exposure to BV risk. One study found that the detection of spermatozoa on a Gram stain was the sole correlate of incident BV in their analysis.¹⁰ Another found that the presence of prostate-specific antigen, a marker of recent semen exposure, was significantly associated with prevalent BV.¹¹ Semen is alkaline, which temporarily raises vaginal pH and could create conditions favorable for Gardnerella adhesion, echoing the lab finding that the bacterium attaches best at a higher pH.

BV and Pregnancy Risk

Clue cells on a wet prep carry extra weight during pregnancy. BV has been consistently associated with preterm birth. A meta-analysis pooling data from multiple studies found that women with BV had roughly twice the odds of delivering preterm compared with women without BV.¹² The overall relative risk was about 1.44, and the overall odds ratio was about 1.79.¹² This is one reason many obstetric providers screen for BV in pregnant women, particularly those with a history of preterm delivery. Whether treating asymptomatic BV in pregnancy actually reduces preterm risk remains an area of ongoing debate, but identifying it is considered an important part of prenatal care.

Clue Cells Do Not Mean You Have a Urinary Tract Infection

Because vaginal wet preps are sometimes done alongside urine testing, a common worry is that clue cells might signal or cause a urinary tract infection. A large study of over 16,000 emergency department visits looked specifically at this question. After adjusting for demographics and urine test results, women with positive clue cells on their wet prep were actually less likely to be diagnosed with a UTI than women without clue cells. Clue cells were not associated with higher bacteria counts in urine cultures and were not linked to the presence of E. coli, the most common UTI pathogen.¹³

BV and UTIs are distinct conditions involving different bacteria in different anatomical locations. If you have clue cells and also have burning or urgency with urination, both conditions could be happening simultaneously, but the clue cells themselves are not the cause of urinary symptoms. They point squarely at what is going on in the vaginal environment, not the bladder.

Limitations of the Wet Prep and Where Diagnostics Are Heading

For all its clinical value, the wet mount is far from a perfect test. Reading a slide is subjective. A clinician has to decide whether enough bacteria are coating a cell to call it a “clue cell” versus a cell that just has some bacteria nearby. Inter-examiner variability has been documented, and the pseudo clue cell phenomenon described earlier shows that even experienced examiners can be fooled. Gram staining of vaginal smears, scored using the Nugent system, is considered the laboratory gold standard for BV diagnosis, but it requires a trained microscopist and is not always available at the point of care.¹⁴

Molecular testing is gaining ground. DNA-based assays can identify the specific bacterial species present and their relative abundances without relying on anyone’s interpretation of what a cell looks like. These techniques are especially useful for catching polymicrobial conditions and biofilm-associated BV that traditional microscopy might miss.¹⁵ On the other end of the technology spectrum, researchers have developed smartphone-based microscopy kits that let a user visualize clue cells without laboratory equipment, paired with paper-strip detection of vaginolysin, a toxin produced by Gardnerella.¹⁶ These kinds of tools could make accurate BV screening possible in low-resource settings where trained microscopists are not available.

Can You Have Clue Cells Without Symptoms?

Yes, and it is common. Many women whose wet preps show clue cells report no discharge, no odor, and no irritation. Because BV represents a shift in the overall microbial community rather than a raging acute infection, the changes can be subtle enough that you never notice them. Whether asymptomatic BV needs treatment is a judgment call that depends on context. In non-pregnant women with no symptoms, some providers take a watch-and-wait approach since the condition sometimes resolves on its own when the vaginal ecosystem rebalances. In pregnant women, the calculus shifts because of the preterm birth association described above. In anyone about to undergo a gynecologic procedure such as an IUD insertion or a hysterectomy, treating asymptomatic BV beforehand may reduce the risk of post-procedure infection.

If you are reading a wet prep report and see “clue cells present” alongside normal white blood cell counts and no trichomonads, what you are looking at is a straightforward BV finding. Elevated white blood cells would point more toward an inflammatory process like trichomoniasis or a yeast infection. BV is characteristically non-inflammatory, which is one reason it can be so stealthy. The bacteria are causing a community shift, not triggering the kind of immune response that makes you feel acutely sick.

Why BV Keeps Coming Back and What Researchers Are Exploring

The recurrence rates for BV remain one of the most vexing problems in gynecology. Standard antibiotics clear the symptoms effectively in the short term, but the polymicrobial biofilm on the vaginal wall acts as a reservoir. Gardnerella vaginalis is particularly adept at forming these biofilms, which shield the bacteria inside from antibiotic exposure. Even a course of treatment that feels successful may leave small pockets of biofilm intact, ready to regrow once the antibiotic pressure lifts.

Current research is exploring several strategies. Biofilm disruptors, compounds designed to break apart the biofilm’s structural matrix so antibiotics can reach the bacteria inside, are in early-stage trials. Vaginal microbiota transplantation, conceptually similar to fecal transplants for gut infections, involves introducing Lactobacillus-dominated vaginal fluid from a healthy donor. The idea is to re-establish a protective microbial community that keeps Gardnerella in check long-term. Whether this approach will prove safe and effective at scale remains to be seen, but early interest is high. Probiotic formulations containing specific Lactobacillus strains are also being studied as adjuncts to antibiotic therapy, with the goal of reducing recurrence by giving the beneficial bacteria a head start in recolonizing the vaginal environment after treatment ends.

For now, if your wet prep shows clue cells and you have been through this cycle before, the most practical steps are completing the full course of prescribed antibiotics, discussing suppressive therapy options with your provider if recurrence is frequent, and being aware that condom use may reduce the pH disruption associated with semen exposure. None of these strategies is a guarantee, but they address the factors most clearly linked to BV onset and return.